![Marc-André Blais](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Marc-André Blais
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Prognomix, Inc.
![]() Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | - | - |
Unternehmenssekretär | - | - |
Karriereverlauf von Marc-André Blais
Statistik
International
Kanada | 2 |
Operativ
Director/Board Member | 1 |
Corporate Secretary | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Prognomix, Inc.
![]() Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Health Technology |
- Börse
- Insiders
- Marc-André Blais
- Erfahrung